Rinaldo Pellicano

Summary

Publications

  1. ncbi Helicobacter pylori and coronary heart disease: which directions for future studies?
    Rinaldo Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Crit Rev Microbiol 29:351-9. 2003
  2. ncbi Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine
    F Pallavicino
    Department of Gastroenterology and Hepatology, Molinette Hospital, Torino, Italy
    Eur Rev Med Pharmacol Sci 17:84-7. 2013
  3. ncbi Skin ulcer pain
    R Pellicano
    Department of Gastroenterology and Hepatology, Molinette Hospital, Turin, Italy
    Minerva Med 103:525-31. 2012
  4. ncbi Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view
    Carmelo Luigiano
    Unit of Gastroenterology, ARNAS Garibaldi, Catania, Italy
    Infect Disord Drug Targets 12:340-5. 2012
  5. ncbi Hepatitis C virus and human immunodeficiency virus: a dangerous dealing
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 49:79-82. 2007
  6. ncbi Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 51:55-61. 2005
  7. ncbi Strategies for the diagnosis of gastro-esophageal reflux disease
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 50:193-203. 2004
  8. ncbi The epidemiology of hepatitis C virus infection. An update for clinicians
    R Pellicano
    Unit of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 50:1-7. 2004
  9. ncbi Is hepcidin the bridge linking Helicobacter pylori and anemia of chronic infection? A research proposal
    R Pellicano
    UOADU Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 46:165-9. 2004
  10. ncbi Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection
    Rinaldo Pellicano
    UOADU Gastro Hepatology, Molinette Hospital, Turin, Italy
    Dig Dis Sci 49:395-8. 2004

Collaborators

Detail Information

Publications102 found, 100 shown here

  1. ncbi Helicobacter pylori and coronary heart disease: which directions for future studies?
    Rinaldo Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Crit Rev Microbiol 29:351-9. 2003
    ....
  2. ncbi Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine
    F Pallavicino
    Department of Gastroenterology and Hepatology, Molinette Hospital, Torino, Italy
    Eur Rev Med Pharmacol Sci 17:84-7. 2013
    ..However, AZA tends to exter varied well-known toxicity. Since the rate of hepato-pancreatic side-effects in patients with IBD and PSC is still unclear, we investigated this issue...
  3. ncbi Skin ulcer pain
    R Pellicano
    Department of Gastroenterology and Hepatology, Molinette Hospital, Turin, Italy
    Minerva Med 103:525-31. 2012
    ..Therefore, this combination allows to obtain a quick and long lasting effect with a high tolerability profile also when treating skin ulcer pain...
  4. ncbi Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view
    Carmelo Luigiano
    Unit of Gastroenterology, ARNAS Garibaldi, Catania, Italy
    Infect Disord Drug Targets 12:340-5. 2012
    ..pylori infection and GC, focusing on the potential benefits of bacterial eradication in slowing down or in inducing regression of precancerous lesions...
  5. ncbi Hepatitis C virus and human immunodeficiency virus: a dangerous dealing
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 49:79-82. 2007
    ..Mortality among HIV-infected liver transplant recipients is similar to that of age and race-matched HIV-negative controls. The present concise review attempts to highlight on the current clinical situation on HIV/HCV coinfection...
  6. ncbi Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 51:55-61. 2005
    ..This antiviral drug can induce or exacerbate a multitude of autoimmune-related disorders, however, clinically overt immune-mediated diseases are rare and affect a subset of subjects who have an underlying autoimmune diathesis...
  7. ncbi Strategies for the diagnosis of gastro-esophageal reflux disease
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 50:193-203. 2004
    ..Further studies are required to delineate the appropriate use and the possible impact of new techniques, such as intraluminal impedance monitoring, Bilitec and, wireless ambulatory pH monitoring in the management of GERD...
  8. ncbi The epidemiology of hepatitis C virus infection. An update for clinicians
    R Pellicano
    Unit of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 50:1-7. 2004
    ....
  9. ncbi Is hepcidin the bridge linking Helicobacter pylori and anemia of chronic infection? A research proposal
    R Pellicano
    UOADU Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 46:165-9. 2004
    ..pylori and iron-deficiency anemia and, we propose to evaluate a possible mechanism involving hepcidin in a bridging role linking the infection to the anemia...
  10. ncbi Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection
    Rinaldo Pellicano
    UOADU Gastro Hepatology, Molinette Hospital, Turin, Italy
    Dig Dis Sci 49:395-8. 2004
    ..9%), SMA in 3 of 38 (7.9%), and anti-LKM-1 in 0 patients. The difference was not statistically significant. In this population, H. pylori infection is not associated with an increased prevalence of NOSAs...
  11. ncbi A rare location of Crohn's disease: the nasal mucosa
    Rinaldo Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Acta Biomed 82:74-6. 2011
    ....
  12. ncbi Molecular findings on Helicobacter pylori: update for clinicians
    C Morace
    Department of Medicine and Pharmacology, University of Messina, Italy
    Minerva Gastroenterol Dietol 57:387-94. 2011
    ..In this review, we have set ourselves the target of summarising the latest progress made in understanding the molecular aspects of H. pylori infection of notable importance for the physician...
  13. ncbi How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 47:191-4. 2005
    ..Most studies have been carried out in microbiological settings, while only few have been conducted in clinical frames. We evaluated the accuracy of culture for detection of H. pylori in a clinical dedicated laboratory...
  14. ncbi Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication
    R Pellicano
    Gastro Hepatology Unit, S Giovanni Battista Molinette Hospital, Turin, Italy
    Int Angiol 28:469-73. 2009
    ..In order to investigate this issue, the authors assessed changes in clinical and biochemical parameters related to IHD after bacterial eradication...
  15. ncbi Women and celiac disease: association with unexplained infertility
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Med 98:217-9. 2007
    ..However, this remains a speculation. In conclusion, each woman with unexplained infertility should be screened for CD...
  16. ncbi Risk factors for HCV infection. Focus on ethnic and cultural characteristics
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 55:159-62. 2009
    ..With the current globalization and large-scale migrations, only by following a preventive strategy based on disseminate information risk behaviours may be modified...
  17. ncbi Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Via Chiabrera 34, 10126 Turin, Italy
    Panminerva Med 48:241-6. 2006
    ..pylori infection on the prevention or the reduction of recurrence in subjects with IHD, should be performed in order to provide support of a causal relationship. This represents a promising direction for future studies...
  18. ncbi Stem cells and Helicobacter-induced gastric cancer: where do we stand at the end of 2006
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 48:175-9. 2006
    ..Due to several reasons, in humans, data are conflicting. Further studies may shed light on the molecular bases of gastric lesions, leading to the development of preventive strategies...
  19. ncbi Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot study
    R Pellicano
    University Department of Gastro Hepathology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 55:227-35. 2009
    ..This prospective study evaluated the benefit of treatment with a dietary integrator composed of sodium alginate, sodium bicarbonate, bromelin and essential oils...
  20. ncbi Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view
    R Pellicano
    Department of Gastro Hepatology, San Giovanni Battista Molinette Hospital, Turin, Italy
    Panminerva Med 48:33-40. 2006
    ..Moreover, they have an antiproliferative effect. Chemotherapy, interferon and embolisation are indicated in rapidly evolving tumours or in cases in which the tumoral symptoms cannot be treated by other approaches...
  21. ncbi [Gastric cancer and Helicobacter pylori: an interdisciplinary point of view]
    R Pellicano
    S C D U Gastro Epatologia, Azienda Ospedaliera, San Giovanni Battista, Turin, Italy
    Minerva Med 97:31-8. 2006
    ..The sole exception is Japan where this malignancy is often identified at an early stage when cure by radical surgery is more probable...
  22. ncbi [Non-invasive diagnosis of Helicobacter pylori infection in the 2006 clinical practice]
    R Pellicano
    S C D U Gastro Epatologia, Azienda Ospedaliera San Giovanni Battista Molinette, Turin, Italy
    Minerva Med 97:19-24. 2006
    ..Confirmation of H. pylori eradication following treatment should be tested by UBT; the stool antigen assay is the alternative if the former is not available...
  23. ncbi Epilepsy and celiac disease: review of literature
    D G Ribaldone
    Department of Gastroenterology and Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 53:213-6. 2011
    ..In fact, the clinical spectrum of epilepsy related to CD ranges from benign syndromes to intractable epilepsy. The precise mechanism of the potential association between CD and epilepsy is also still under discussion...
  24. ncbi [Helicobacter pylori infection in pediatrics. Present knowledge and practical problems]
    R Pellicano
    Cattedra di Gastroenterologia, Universita degli Studi, Torino
    Minerva Pediatr 52:29-45. 2000
    ..Regimens suggested for H. pylori eradication are a combination of inhibitors of gastric acid secretion plus two antibiotics for 7-10 days...
  25. ncbi Ischemic cardiovascular disease and Helicobacter pylori. Where is the link?
    R Pellicano
    Department of Gastro Hepatology, Hospital Molinette, Turin, Italy
    J Cardiovasc Surg (Torino) 41:829-33. 2000
    ..pylori and CHD...
  26. ncbi [Infections and cardiovascular diseases on an ischemic basis. The case of Helicobacter pylori]
    R Pellicano
    Cattedra di Gastroenterologia, Dipartimento di Medicina Interna, Azienda Ospedaliera, Universita degli Studi, Torino
    Minerva Med 91:161-7. 2000
    ....
  27. ncbi Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
    Rinaldo Pellicano
    Department of Gastro Hepatology, San Giovanni Battista Molinette Hospital, Torino, Italy
    J Med Virol 80:628-31. 2008
    ..49; 95% CI: 0.28-0.85). Serum uric acid level > or =5.8 mg/dl is predictive of poor response to HCV treatment. Prospective studies are needed to clarify the issue...
  28. ncbi The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer
    R Pellicano
    Department of Internal Medicine, University of Turin, Italy
    J Clin Gastroenterol 32:222-4. 2001
    ..pylori after cure was nil at 4 years, and that long-term inhibition of acid secretion may not improve outcome after cure of H. pylori, even in patients whose DU was complicated by hemorrhage...
  29. ncbi The role of gastroesophageal reflux disease in chest pain
    R Pellicano
    UOADU Gastro Hepatology, Molinette Hospital, Turin, Italy
    J Cardiovasc Surg (Torino) 43:553-7. 2002
    ..In conclusion, patients with non-cardiac chest pain of unknown origin should be carefully screened for the occurrence of GERD, but further research is needed to clarify the role of the latter on the pathogenesis of this symptom...
  30. ncbi [Gastroenterologists in ambulatory care. The experience in Turin in the year 2000]
    R Pellicano
    Ambulatori di Gastro Epatologia, Azienda Ospedaliera San Giovanni Battista, Molinette, Turin, Italy
    Minerva Med 92:79-83. 2001
    ..To the experienced gastroenterologist it is clear that a large number of hospitalisation is linked to a lack of careful outpatient follow-up of diseases such as cirrhosis, ulcerative colitis and peptic ulcer...
  31. ncbi Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin
    Renato Bonardi
    Department of Gastroenterology and Hepatology, Molinette Hospital, 88 Corso Bramante, 10100 Turin, Italy
    Biomed Pharmacother 65:303-6. 2011
    ..This study evaluated the impact of rapid virological response (RVR) in HCV genotype 1b infection management...
  32. ncbi Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma
    Nicola Leone
    Department of Gastro-Hepatology, Molinette Hospital, Via Chiabrera 34, 10126 Turin, Italy
    Cancer Detect Prev 27:494-7. 2003
    ..05); 11 out of 16 (68.7%) female patients were seropositive versus 9 out of 16 (56.2%) control subjects (P=n.s.). CONCLUSION: Seroprevalence of antibodies to H. pylori was found to be higher in patients with HCC than in controls...
  33. ncbi Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study
    Chiara Giordanino
    Division of Gastroenterology, University of Turin, San Luigi Medical School, Orbassano, Italy
    Dig Liver Dis 44:406-12. 2012
    ....
  34. ncbi Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study
    Chiara Giordanino
    Gastroenterology, Molinette Hospital, Turin, Italy
    Am J Gastroenterol 103:2481-7. 2008
    ..Patients with chronic hepatitis C are at risk of developing type 2 diabetes mellitus (DM) and impaired fasting glucose (IFG), and this risk may increase among hepatitis C virus (HCV) patients not responding to an antiviral therapy...
  35. ncbi Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis
    Marilena Durazzo
    Department of Internal Medicine, University of Turin, Corso A M Dogliotti 14, 10126 Turin, Italy
    World J Gastroenterol 10:3179-81. 2004
    ..To determine the association between seroprevalence of Helicobacter pylori (H pylori) infection and primary biliary cirrhosis (PBC)...
  36. ncbi Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma
    Rinaldo Pellicano
    Ambulatorio di Gastroenterologia, Ospedale S Giovanni Battista, Via Chiabrera 34, III piano, 10126 Torino, Italy
    World J Gastroenterol 10:598-601. 2004
    ..CONCLUSION: Helicobacter spp., carcinogenic in mice, were found at a higher frequency in the liver of patients with HCV-related cirrhosis and HCC than those in patients without primary liver disease...
  37. ncbi Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study
    Emanuela Faga
    Department of Internal Medicine, Savigliano Hospital, Savigliano CN, Italy
    Eur J Gastroenterol Hepatol 24:70-6. 2012
    ..The aim of this study was to investigate whether the use of propofol is safe for endoscopic procedures more complex than gastroscopy in patients with liver cirrhosis in a prospective controlled study...
  38. ncbi Preliminary experience with a new cytology brush in EUS-guided FNA
    Mauro Bruno
    Department of Gastro Hepatology, Molinette Hospital, Torino, Italy
    Gastrointest Endosc 70:1220-4. 2009
    ..Recently, the EchoBrush (Cook Endoscopy, Winston-Salem, NC), a disposable cytologic brush, was introduced to the market. To date, only 1 study, limited to 10 pancreatic cyst cases, using this device has been published...
  39. ncbi Helicobacter species and liver diseases: association or causation?
    Rinaldo Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Lancet Infect Dis 8:254-60. 2008
    ..More studies are therefore needed to confirm whether a causal association exits between the presence of Helicobacter spp in the liver and the development of cirrhosis and hepatocellular carcinoma...
  40. ncbi Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast
    Giovanni C Actis
    Department of Gastro Hepatology, Ospedale Gradenigo, 10153 Torino, Italy
    Inflamm Allergy Drug Targets 9:6-9. 2010
    ..These results are likely to influence the medical choices of inflammatory bowel disease caregivers in the decades to come...
  41. ncbi Overlap syndromes of autoimmune hepatitis: what is known so far
    Marilena Durazzo
    Department of Internal Medicine, University of Turin, Italy
    Dig Dis Sci 48:423-30. 2003
    ....
  42. ncbi Occult hepatitis B virus infection in patients with chronic hepatitis C treated with antiviral therapy
    Gian Paolo Caviglia
    Department of Internal Medicine, University of Turin, Turin, Italy
    Hepat Mon 12:e7292. 2012
    ..The impact of OBI in patients with chronic hepatitis C (CHC) is still unclear...
  43. ncbi The practice of percutaneous liver biopsy in a gastrohepatology day hospital: a retrospective study on 835 biopsies
    Giovanni Clemente Actis
    Department of Gastro Hepatology and Clinical Nutrition, San Giovanni Battista Molinette Hospital, Torino, 10126, Italy
    Dig Dis Sci 52:2576-9. 2007
    ..In conclusion, these data accord with indications expressed by international guidelines. The impact of liver biopsy on therapeutic decision-making needs to be studied further...
  44. ncbi Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease
    Daniele Simondi
    Department of Gastrohepatology, San Giovanni Battista Hospital of Turin, Turin, Italy
    Inflamm Bowel Dis 14:645-51. 2008
    ..The objective of the study was to evaluate the diagnostic accuracy of recently developed antiglycan serological tests in clinical practice for the diagnosis of Crohn's disease...
  45. ncbi Association of Helicobacter pylori infection with ischemic stroke of non-cardiac origin: the BAT.MA.N. project study
    Antonio Ponzetto
    Department of Gastroenterology, Molinette Hospital, Turin, Italy
    Hepatogastroenterology 49:631-4. 2002
    ..The aim of this case-controlled study was to evaluate the prevalence of H. pylori infection in patients with acute ischemic stroke not related to cardiac causes...
  46. ncbi The natural history of gastrointestinal subepithelial tumors arising from muscularis propria: an endoscopic ultrasound survey
    Mauro Bruno
    Department of Gastro Hepatology, Molinette Hospital, Torino, Italy
    J Clin Gastroenterol 43:821-5. 2009
    ..Aim of this study was to evaluate the natural course of benign-appearing lesions originating from muscularis propria in organs where GISTs significantly overcome leiomyomas...
  47. ncbi Helicobacter pylori seroprevalence in patients with autoimmune hepatitis
    Marilena Durazzo
    Department of Internal Medicine, University of Turin, Italy
    Dig Dis Sci 47:380-3. 2002
    ..28). The difference was not statistically significant either in female or male patients. In conclusion, the prevalence of H. pylori infection in patients and controls was similar in our study of patients with chronic autoimmune hepatitis...
  48. ncbi Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection
    A Ponzetto
    Department of Gastroenterology, Ospedale S Giovanni Battista, c so Bramante 88, 10126, Torino, Italy
    Neth J Med 56:206-10. 2000
    ..pylori were present in 40/45 (89%) patients and 183/310 (59%) blood donors (P<0.001). This very high prevalence of H. pylori may explain the frequent occurrence of gastroduodenal ulcer in cirrhotic patients. (See Editorial p. 203)..
  49. ncbi Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    New Microbiol 25:315-21. 2002
    ..The classical risk factors for coronary disease were present in the patients with AMI irrespective of H. pylori status...
  50. ncbi Commonalities and differences between Crohn's disease and ulcerative colitis: the genetic clues to their interpretation
    Giovanni C Actis
    Department of Gastro Hepatology, Ospedale Gradenigo, Torino, Italy
    Inflamm Allergy Drug Targets 10:447-54. 2011
    ..In this review we touched on two pathways that make true susceptibility genes for inflammatory bowel diseases; gene loci that confer specific risk for ulcerative colitis and Crohn's disease were discussed in detail...
  51. ncbi Helicobacters and extragastric diseases
    Rinaldo Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Helicobacter 14:58-68. 2009
    ..pylori eradication. There is also growing evidence of the role of H. pylori in other diseases, including ischemic heart disease even though results are not conclusive...
  52. ncbi Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection
    Rinaldo Pellicano
    U.O.A.D.U. Gastro-Hepatology, Hospital S Giovanni Battista (Molinette, Torino, Italy
    Eur J Gastroenterol Hepatol 14:1377-82. 2002
    ..However, the results of the trial do not support the use of IFN-beta monotherapy in patients with chronic hepatitis C that is resistant to IFN-alpha...
  53. ncbi Pancreatic cancer imaging: the new role of endoscopic ultrasound
    Claudio De Angelis
    Gastrohepatology Department, San Giovanni Battista Hospital, University of Turin Turin, Italy
    JOP 8:85-97. 2007
    ..In the near future, there will be great opportunities for the development of diagnostic and therapeutic EUS and pancreatic cancer could be the best testing ground...
  54. ncbi [Ischemic cardiovascular diseases. Correlation with Helicobacter pylori infection]
    R Pellicano
    UOADU Gastro Epatologia Azienda Ospedaliera San Giovanni Battista Molinette, Torino
    Minerva Cardioangiol 48:467-73. 2000
    ..pylori has a causal role in the pathogenesis of acute myocardial infarction and ischemic stroke...
  55. ncbi Endoscopic ultrasonography in hepatology: focus on portal hypertension
    C De Angelis
    Department of Gastro Epatology, San Giovanni Battista Molinette, Hospital, Corso Bramante 88, Turin, Italy
    Minerva Gastroenterol Dietol 54:131-9. 2008
    ..Despite having this amount of information, there is lack of scientific evidence that EUS imaging and EUS-assisted therapy can have a clear-cut clinical impact and affect patients outcome...
  56. ncbi EUS in gastroenterology. New challenges after Turin 2007
    C De Angelis
    Department of Gastro-Hepatology, Molinette Hospital, Corso Bramante 88, Turin, Italy
    Minerva Gastroenterol Dietol 54:123-4. 2008
  57. ncbi [Lithiasis of the gallbladder and biliary ducts: from epidemiology to therapy]
    R Pellicano
    UOADU Gastro Epatologia, Azienda Ospedaliera, San Giovanni Battista Molinette, Turin, Italy
    Minerva Med 92:227-43. 2001
    ..Indication to surgical ablation is a symptomatic or complicated cholelithiasis, or the history of obstructive pancreatitis. A preventive cholecystectomy can be useful for precancerous lesions...
  58. ncbi An update on AIDS-related cholangiopathy
    C De Angelis
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 55:79-82. 2009
    ....
  59. ncbi Instruments and accessories for diagnostic endoscopic ultrasound (radial scanning and miniprobes)
    C De Angelis
    Department of Gastrohepatology, Molinette Hospital, Turin, Italy
    Minerva Med 98:253-60. 2007
    ....
  60. ncbi Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study
    F Palmas
    UOADU Gastro-Hepatology, Ospedale S. Giovanni Battista (Molinette, Turin, Italy
    Panminerva Med 44:145-7. 2002
    ..The 10-day triple therapy, although not significantly, provided a satisfactory treatment against H. pylori infection...
  61. ncbi Gastro-oesophageal reflux disease and asthma: would be possible to improve therapy on the basis of what is now known?
    R Pellicano
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 46:135-40. 2004
    ....
  62. ncbi Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis?
    S Fagoonee
    Department of Biology, Biochemistry and Genetics and Molecular Biotechnology Center, University of Turin, Turin, Italy
    Minerva Med 101:121-5. 2010
    ..This aggregate formation was abrogated by antibodies against specific adhesion molecules (L- and P-selectin). The future challenge is to gain more knowledge in this field and to translate these information into clinical practice...
  63. ncbi Previous tuberculosis, hepatitis C virus and lichen planus. A report of 10 cases, a causal or casual link?
    R Pellicano
    Department of Gastroenterology, Molinette Hospital, Turin, Italy
    Panminerva Med 42:77-81. 2000
    ..In clinical practice the patients with chronic liver disease and HCV infection can also suffer from severe extrahepatic manifestations, including lichen planus...
  64. ncbi [Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report]
    R Pellicano
    Ambulatori di Gastro Epatologia, S C D U Gastro Epatologia, Azienda Ospedaliera, San Giovanni Battista, Molinette, Torino, Italy
    Minerva Med 98:19-23. 2007
    ..In this facility, the management is based on a work team organization that follows cohorts of patients with specific pathologies...
  65. ncbi [Helicobacter pylori and headache: a minireview]
    R Pellicano
    S C D U Gastro Epatologia, Azienda Ospedaliera San Giovanni Battista, Molinette, Torino, Italy
    Minerva Med 98:37-41. 2007
    ..Further investigations should focalize on particular subgroups of patients and, encouraged from data produced by intervention studies, evaluate the long-term benefit of eradication...
  66. ncbi Assessment of liver fibrosis in the clinical setting: something is changing?
    M Berrutti
    Unit of Gastro Hepatology, S Giovanni Battista Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 53:111-4. 2007
    ..Since its use in the clinical setting is of great interest, further studies should define the exact role of this procedure...
  67. ncbi An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series
    Giovanni C Actis
    Division of Gastroenterology, Ospedale Molinette, Torino, Italy
    Curr Clin Pharmacol 7:209-13. 2012
    ..We studied the toxicity of cyclosporin (CsA), azathioprine, and mesalamine in 94 patients with inflammatory bowel disease (IBD)...
  68. ncbi Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures
    Alessandro Repici
    Department of Gastroenterology and Clinical Nutrition, Molinette Hospital, Torino, Italy
    Gastrointest Endosc 60:513-9. 2004
    ....
  69. ncbi Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?
    A Ponzetto
    Department of Gastroenterology, Hospital San Giovanni Battista, Torino, Italy
    Med Hypotheses 54:275-7. 2000
    ..Together, these findings support the proposal that H. pylori is implicated in the pathogenesis and progression of cirrhosis, particularly in HCV-infected individuals. Involvement of Helicobacter spp. in HCC also seems highly possible...
  70. ncbi Chronic Helicobacter pylori infection and migraine: a case-control study
    L Pinessi
    Neurology III-Headache Center, Department of Neuroscience, University of Turin, Italy
    Headache 40:836-9. 2000
    ..CONCLUSIONS: Our study suggests that chronic Helicobacter pylori infection is not more frequent in patients with migraine than in controls and that infection does not modify clinical features of the disease...
  71. ncbi [Gastroesophageal reflux disease and chest pain]
    R Pellicano
    Azienda Ospedaliera, S. Giovanni Battista, Molinette, Turin, Italy
    Minerva Cardioangiol 49:197-209. 2001
    ..Patients with non-cardiac chest pain of unknown origin should be carefully screened for the occurrence of GERD...
  72. ncbi Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseases
    A Ponzetto
    Department of Internal Medicine, University of Turin
    New Microbiol 26:321-8. 2003
    ....
  73. ncbi [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations]
    M Berrutti
    S C D U Gastro Epatologia, Azienda Ospedaliera San Giovanni Battista, Molinette, Torino
    Minerva Gastroenterol Dietol 53:153-6. 2007
    ..pylori infection in order to modify the natural history of GERD. In this review, the authors report the main updated considerations regarding this matter...
  74. ncbi [Intestinal metaplasia, dysplasia, gastric cancer and Helicobacter pylori: epidemiological observations]
    R Pellicano
    SCDU Gastro-Epatologia, Azienda Ospedaliera San Giovanni Battista, Torino, Italy
    Minerva Med 96:1-10. 2005
    ..pylori and GC are discussed. Prospective cohort studies and interventional trials focused on the effects of H. pylori eradication on lesions predisposing to GC should be performed in order to provide further data...
  75. ncbi Potential applications of germline cell-derived pluripotent stem cells in organ regeneration
    Sharmila Fagoonee
    University of Turin, Italy
    Organogenesis 7:116-22. 2011
    ..Potential problems related to their use are also highlighted...
  76. ncbi The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis
    Giovanni C Actis
    Department of Digestive Disease and Nutrition, Ospedale Molinette, c so Bramante 88, Torino, Italy
    Biomed Pharmacother 63:362-5. 2009
    ..By contrast, the toxicity rates were higher than expected. Failure to genotype or to use escalating AZA doses can only be hypothesized as causes...
  77. ncbi Helicobacter pylori infection and diabetes
    V Ojetti
    Department of Internal Medicine, Catholic University, Rome, Italy
    Minerva Med 101:115-9. 2010
    ..pylori strain selection. Finally, a higher H. pylori re-infection rate in DM patients than in general population has been shown...
  78. ncbi Helicobacter pylori seropositivity in patients with unstable angina
    R Pellicano
    Department of Gastro-Hepatology, Molinette Hospital, Turin, Italy
    J Cardiovasc Surg (Torino) 44:605-9. 2003
    ..pylori than the control population. Classical risk factors for ischemic heart disease, such as the indicators of socio-economic status, were equally distributed among infected or uninfected patients with UA...
  79. ncbi Role of Helicobacter pylori infection in peptic ulcer haemorrhage
    A Morgando
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Med 97:47-50. 2006
    ..The aim of this study was to determine both the prevalence of H. pylori infection and NSAIDs consumption in PUH and their prognostic importance...
  80. ncbi Helicobacter pylori eradication: metronidazole or tinidazole? Data from Turin, Italy
    M Berrutti
    Department of Gastro Hepatology DU, S Giovanni Battista Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 54:355-8. 2008
    ..The aim of this randomized study was to assess the efficacy of a metronidazole-based versus a tinidazole-based treatment, in naïve patients with H. pylori infection...
  81. ncbi Use of corticosteroids, immunomodulators, and infliximab at a third-level Day-Hospital Service of Gastro-Hepatology
    G C Actis
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Minerva Gastroenterol Dietol 54:239-42. 2008
    ..Third-level Day-Hospital Services of Gastro-Hepatology are likely to recruit patients with an increased disease severity. The burden of request for immunomodulation drugs is presently unclear...
  82. ncbi Potential relationship between Helicobacter pylori and ischemic heart disease: any pathogenic model?
    M Berrutti
    Department of Gastro Hepatology, S Giovanni Battista Hospital Molinette, Turin, Italy
    Panminerva Med 50:161-3. 2008
    ..In conclusion, because IHD is a multifactorial disease, it is evident that H. pylori is not the only cause. Thus, the definition of H. pylori or other infectious agents as culprits requires a multidisciplinary approach...
  83. ncbi The diagnosis of gastroesophageal reflux disease
    L Dughera
    Service of Motility and Digestive Endoscopy, Turin, Italy
    Minerva Gastroenterol Dietol 53:143-52. 2007
    ..Manometry is mandatory prior to any surgical approach and to verify motility disorders that could be associated to GERD...
  84. ncbi Helicobacter pylori and dementia. Which consistency for an association?
    M Berrutti
    Department of Gastro Hepatology, Molinette Hospital, Turin, Italy
    Panminerva Med 49:227-30. 2007
    ..pylori and dementia...
  85. ncbi The esophageal chest pain. An update for clinicians
    M Durazzo
    Department of Internal Medicine, University of Turin, Turin, Italy
    Panminerva Med 44:61-7. 2002
    ..Patients with non-cardiac chest pain of unknown origin should be carefully screened for the occurrence of esophageal disorders but further research is needed to clarify the role of the latter on the pathogenesis of this symptom...
  86. ncbi Laparoscopic cholecystectomy in cirrhotic patients
    N Leone
    Department of Gastroenterology, Molinette Hospital, Turin, Italy
    Dig Surg 18:449-52. 2001
    ..Laparoscopic cholecystectomy has become the procedure of choice for symptomatic cholelithiasis. A study to evaluate the benefits and risks of laparoscopic cholecystectomy in cirrhotic patients was performed...
  87. ncbi Absence of gene mutations in a case of concomitant presence of carcinoid of the ampulla of vater pheochromocytoma and Von Recklinghausen disease
    G Olivero
    Department of Medical and Surgical Sciences University of Turin, Turin, Italy
    Minerva Gastroenterol Dietol 52:437-40. 2006
    ..The results demonstrated that no somatic or germline mutations in the MEN-1 and MEN-2 genes were involved in the pathogenesis of these tumours...
  88. ncbi The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species
    S Fagoonee
    Department of Biology Biochemistry and Genetics, University of Turin, Turin, Italy
    Panminerva Med 43:279-82. 2001
    ..Future research is needed to clarify the importance of Helicobacter spp. in respect to the other pathogens already known as causative agents of chronic inflammation of the liver and its long term sequelae, namely cirrhosis and HCC...
  89. ncbi Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations
    N Leone
    Department of Gastroenterology, Molinette Hospital, Turin, Italy
    J Med Virol 66:200-3. 2002
    ..These results suggest that HCV infection should be considered in the differential diagnosis of rheumatological symptoms of unknown origin...
  90. ncbi Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study
    M Astegiano
    SC Gastro Epatologia DU, Ospedale S Giovanni Battista, Molinette C so Bramante 88, Torino, Italy
    Biomed Pharmacother 61:370-6. 2007
    ..These results clearly suggest that oral BDP coated tablets are effective and safe for treatment of mild-to-moderate Crohn's disease of ileal or ileal-right colonic localisation...
  91. ncbi Role of endoscopic ultrasound in biliary and unexplained pancreatitis
    R Pellicano
    Unit of Gastro Hepatology, San Giovanni Battista Hospital, Turin, Italy
    Minerva Med 98:361-5. 2007
    ..The present short review attempts to update on the indications for the employment of EUS in the diagnosis of biliary stones as well as in the clarification of aetiology in the case of unexplained pancreatitis...
  92. ncbi Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis
    S Fagoonee
    Molecular Biotechnology Center, University of Turin, Turin, Italy
    Minerva Gastroenterol Dietol 55:37-40. 2009
    ..In conclusion, ASCA positivity does not imply that there exists a distinct subgroup of patients with AIH and these autoantibodies are not involved in the pathogenetic mechanism of AIH...
  93. ncbi Gastrointestinal problems in the elderly
    M Durazzo
    Department of Internal Medicine, Molinette Hospital, University of Turin, Turin, Italy
    Panminerva Med 49:151-8. 2007
    ..Idiopathic (or autoimmune) chronic pancreatitis in the elderly is more frequent than other forms of pancreatic diseases, like alcoholic pancreatitis...
  94. ncbi Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C
    Rinaldo Pellicano
    U.O.A.D.U. Gastro-Epatologia, Ospedale S. Giovanni Battista (Molinette, Corso Bramante 88-10126 Torino, Italy
    World J Gastroenterol 11:4484-9. 2005
    ..CONCLUSION: Recombinant human IFN beta-1a, alone or in combination with ribavirin, has an excellent safety profile and, may represent an alternative for chronic hepatitis C patients who are unable to tolerate pegylated alpha-interferon...
  95. ncbi Helicobacter pylori and coronary artery disease: which is the better target population?
    Rinaldo Pellicano
    Dig Dis Sci 52:3041-2. 2007
  96. ncbi Helicobacter pylori and type 2 diabetes mellitus. Negative results and goals of future studies
    Rinaldo Pellicano
    Saudi Med J 29:1213. 2008
  97. ncbi Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy
    Giorgio Palestro
    Department of Oncology, University of Torino, 10126 Torino, Italy
    World J Gastroenterol 11:7131-5. 2005
    ....
  98. ncbi Helicobacter pylori and ischemic heart disease. Which potential pathogenic mechanisms?
    Rinaldo Pellicano
    Saudi Med J 27:427; author reply 428. 2006
  99. ncbi Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases
    Cosimo Marcello Bruno
    Department of Internal Medicine and Sistemic Diseases, University of Catania, Italy
    World J Gastroenterol 10:1353-6. 2004
    ..To investigate the serum erythropoietin (Epo) levels in patients with chronic liver diseases and to compare to subjects with iron-deficiency anaemia and healthy controls...
  100. ncbi Erythropoietin in liver cirrhosis: two questions without answers
    Cosimo-Marcello Bruno
    World J Gastroenterol 11:3649. 2005
  101. ncbi Circulating erythropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study
    Cosimo M Bruno
    Department of Internal Medicine and Systemic Diseases, University of Catania, Catania, Italy
    J Diabetes Complications 20:376-9. 2006
    ....